Abbott Laboratories has sued to prevent Watson Pharmaceuticals Inc. from commercializing a generic version of the cholesterol drug Niaspan before the drug’s patents expire.
Abbott sues to block sales of drug in generic form before patents expire
What's New
BizPeople
Submit a BizPeople
Share new hires, promotions and employee accolades with the region's business leaders.